Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
LEI: 213800NNT42FFIZB1T09 16 December 2025 Transactions in Own Shares Foresight Group Holdings Limited ("Foresight", the "Group"), a leading investment manager in real assets and providing capital...
-
ICG Enterprise Trust plc (the “Company”) 16 December 2025 Transaction in Own Shares The Company announces that on 15 December 2025 it bought back 10,000 of its own shares, to be held as treasury...
-
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS NB...
-
Nedenfor følger informasjon om transaksjoner foretatt under fjerde transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2025. Dato for når...
-
VANCOUVER, British Columbia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSXV: AOT.H; OTCID: AOTVF) (“Ascot” or the “Company”) is pleased to announce the closing of its rights offering...
-
Sampo Oyj, pörssitiedote, 16.12.2025 klo 8.30 Sampo Oyj:n omien osakkeiden ostot 15.12.2025 Sampo Oyj (Y-tunnus 0142213-3, LEI 743700UF3RL386WIDA22) on hankkinut omia A-osakkeitaan (ISIN-koodi...
-
Sampo plc, stock exchange release, 16 December 2025 at 8:30 am EET Sampo plc’s share buybacks 15 December 2025 On 15 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has...
-
CHICAGO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Federal Life Group, Inc. (“Federal Life”), a leading provider, through its affiliates, of insurance and retirement solutions founded in 1899, announced its...
-
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fountain Asset Corp. (TSXV:FA) (“Fountain” or the “Company”) wishes to announce that the board of directors of the Company has approved the granting of...
-
MISSISSAUGA, Ontario, Dec. 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...